Docetaxel - Moligand™, ≥98% , Inhibitor of tubulin beta class I, CAS No.114977-28-5, Inhibitor of tubulin beta class I

CAS: 114977-28-5 Cat. No.: D107320 Molecular Weight: 807.88 EC Number: 601-339-2
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Synonyms
Docetaxel [INN] | D07866 | NSC 759850 | Lead di(acetate) | NCGC00242509-01 | DOCETAXEL MYLAN | Ethanol, 2,2'-iminodi-, 3,5-diiodo-4-oxo-1(4H)-pyridineacetate (salt) | KS-1452 | NCGC00181306-01 | DB12492 | Docetaxel anhydrous | Docetaxol | EmDOC | Q-100074
Storage
Store at 2-8°C
Shipped In
Wet ice
 ·  off list, applied to all prices below.
Size
Status
Price
Qty
10mg
D107320-10mg
2
$9.90
20mg
D107320-20mg
3
$14.90
50mg
D107320-50mg
1
$29.90
100mg
D107320-100mg
3
$47.90
250mg
D107320-250mg
3
$89.90
500mg
D107320-500mg
2
$129.90
1g
D107320-1g
2
$187.90
5g
D107320-5g
1
$657.90
Enter a quantity for the sizes you want to add.
🧪

Why this grade

Moligand™, ≥98% Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at 2-8°C Ships Wet ice Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 66 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

Docetaxel(Taxotere), an analog of taxol, is an inhibitor of depolymerisation of microtubules through binding to stabilized microtubules.
Docetaxel can be used to study antibiotics, cell biology, cell signaling, neuroscience and apoptosis and the cell cycle.

Specifications

Synonyms
Docetaxel [INN] | D07866 | NSC 759850 | Lead di(acetate) | NCGC00242509-01 | DOCETAXEL MYLAN | Ethanol, 2, 2'-iminodi-, 3, 5-diiodo-4-oxo-1(4H)-pyridineacetate (salt) | KS-1452 | NCGC00181306-01 | DB12492 | Docetaxel anhydrous | Docetaxol | EmDOC | Q-100074
Specifications & Purity
Moligand™, ≥98%
Biochemical and Physiological Mechanisms
Docetaxel is a taxane anti-cancer agent related to paclitaxel. It binds to and stabilizes the β?tubulin subunit of microtubules, preventing depolymerization of the mitotic spindle thus leading to cell cycle arrest and apoptosis.Potent cytotoxic agent in v
Storage
Store at 2-8°C
Shipped In
Wet ice
This product requires cold chain shipping. Ground and other economy services are not available.
Grade
Moligand™
Action Type
INHIBITOR
Mechanism of action
Inhibitor of tubulin beta class I
Note
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Purity
≥98%
Names and Identifiers
Pubchem Sid504757314
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/504757314
Canonical SmilesCC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
IUPAC Name[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
InChIKeyZDZOTLJHXYCWBA-VCVYQWHSSA-N
INCHI1S/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52)/t26-,27-,28+,30-,31+,32+,33-,35-,41+,42-,43+/m0/s1
Isomeric SMILES CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
WGK Germany 3
RTECS DA4172750
Molecular Weight 807.88
Reaxy-Rn 24720578
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=24720578&ln=

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassLipids and lipid-like molecules
ClassPrenol lipids
SubclassDiterpenoids
Intermediate Tree Nodes Not available
Direct ParentTaxanes and derivatives
Alternative Parents Benzoic acid esters  Tricarboxylic acids and derivatives  Benzoyl derivatives  Fatty acid esters  Monosaccharides  Tertiary alcohols  Carbamate esters  Secondary alcohols  Oxetanes  Carboxylic acid esters  Cyclic alcohols and derivatives  Ketones  Organic carbonic acids and derivatives  Oxacyclic compounds  Polyols  Dialkyl ethers  Hydrocarbon derivatives  Organopnictogen compounds  Organic oxides  Organonitrogen compounds  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Taxane diterpenoid - Benzoate ester - Benzoic acid or derivatives - Tricarboxylic acid or derivatives - Benzoyl - Fatty acid ester - Monocyclic benzene moiety - Fatty acyl - Monosaccharide - Benzenoid - Cyclic alcohol - Carbamic acid ester - Tertiary alcohol - Carboxylic acid ester - Ketone - Carbonic acid derivative - Oxetane - Secondary alcohol - Organoheterocyclic compound - Oxacycle - Ether - Dialkyl ether - Carboxylic acid derivative - Polyol - Organic nitrogen compound - Hydrocarbon derivative - Alcohol - Carbonyl group - Organic oxide - Organonitrogen compound - Organooxygen compound - Organic oxygen compound - Organopnictogen compound - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as taxanes and derivatives. These are diterpenoids with a structure based either on the taxane skeleton, or a derivative thereof. In term of phytochemistry, several derivatives of the taxane skeleton exist: 2(3->20)-abeotaxane, 3,11-cyclotaxane, 11(15->1),11(10->9)-abeotaxane, 3,8-seco-taxane, and 11(15->1)-abeotaxane, among others. More complex skeletons have been found recently, which include the taxane-derived [3.3.3] propellane ring system.
External Descriptors tetracyclic diterpenoid
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
TUBB Tclin Tubulin beta chain (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIN1 Tclin Glutamate (NMDA) receptor subunit zeta 1 (122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CACNA1C Tclin Voltage-gated L-type calcium channel alpha-1C subunit (766 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC29A1 Tclin Equilibrative nucleoside transporter 1 (1711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2B Tclin Alpha-2b adrenergic receptor (4412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (7750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BDKRB2 Tclin Bradykinin B2 receptor (3970 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNA4 Tclin Neuronal acetylcholine receptor protein alpha-4 subunit (1265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC3R Tchem Melanocortin receptor 3 (5659 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Associated Targets(non-human)
Mc4r Melanocortin receptor 4 (1205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
4T1 (1737 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUBB2B Tubulin (2175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (341 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mechanisms of Action
Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

36 results found

Lot NumberCertificate TypeDateItem
C2618368Certificate of AnalysisMar 21, 2026 D107320
C2618369Certificate of AnalysisMar 21, 2026 D107320
C2618370Certificate of AnalysisMar 21, 2026 D107320
I2219402Certificate of AnalysisMar 09, 2026 D107320
K1820061Certificate of AnalysisFeb 05, 2026 D107320
J2524376Certificate of AnalysisNov 08, 2025 D107320
C2205397Certificate of AnalysisSep 08, 2025 D107320
C2205403Certificate of AnalysisSep 08, 2025 D107320
F1828013Certificate of AnalysisAug 15, 2025 D107320
I2306381Certificate of AnalysisJun 10, 2025 D107320
I2306357Certificate of AnalysisJun 10, 2025 D107320
I2306356Certificate of AnalysisJun 10, 2025 D107320
I2306355Certificate of AnalysisJun 10, 2025 D107320
I2306354Certificate of AnalysisJun 10, 2025 D107320
I2306353Certificate of AnalysisJun 10, 2025 D107320
I2306403Certificate of AnalysisJun 10, 2025 D107320
I2306404Certificate of AnalysisJun 10, 2025 D107320
H2409335Certificate of AnalysisAug 19, 2024 D107320
H2409336Certificate of AnalysisAug 19, 2024 D107320
B2506088Certificate of AnalysisAug 19, 2024 D107320
K2111810Certificate of AnalysisJan 04, 2024 D107320
C2205575Certificate of AnalysisDec 11, 2023 D107320
I2306402Certificate of AnalysisSep 16, 2023 D107320
I2304603Certificate of AnalysisSep 16, 2023 D107320
I2306352Certificate of AnalysisSep 16, 2023 D107320
I2306382Certificate of AnalysisSep 11, 2023 D107320
D2525054Certificate of AnalysisSep 11, 2023 D107320
I1924081Certificate of AnalysisApr 11, 2023 D107320
B2306919Certificate of AnalysisFeb 11, 2023 D107320
D2122188Certificate of AnalysisJan 17, 2023 D107320
G2227730Certificate of AnalysisJul 30, 2022 D107320
K1820062Certificate of AnalysisJul 11, 2022 D107320
C2205404Certificate of AnalysisMar 11, 2022 D107320
C2205402Certificate of AnalysisMar 11, 2022 D107320
D2313829Certificate of AnalysisMar 11, 2022 D107320
B2306918Certificate of AnalysisMar 11, 2022 D107320

Show more ⌵

Chemical and Physical Properties
Melt Point(°C)186-191°C
Molecular Weight807.900 g/mol
XLogP31.600
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count14
Rotatable Bond Count13
Exact Mass807.347 Da
Monoisotopic Mass807.347 Da
Topological Polar Surface Area224.000 Ų
Heavy Atom Count58
Formal Charge0
Complexity1660.000
Isotope Atom Count0
Defined Atom Stereocenter Count11
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Documents & Articles
Citations of This Product
References
1. Wei Pei, Yuqing Li, Yixian Wu, Yuan Wu, Ling Cai, Shaozhuo Wang, Shoulin Wang, Jin Chen.  (2023)  A Tumoricidal Lipoprotein Complex Electrostatically Stabilized on Mesoporous Silica as Nanotherapeutics and Nanoadjuvant for Potentiating Immunotherapy of Triple Negative Breast Cancer.  ADVANCED FUNCTIONAL MATERIALS,      [PMID:] [10.1002/adfm.202308117]
2. Shuncheng Yao, Shaobo Wang, Minjia Zheng, Zhuo Wang, Zhirong Liu, Zhong Lin Wang, Linlin Li.  (2023)  Implantable, Biodegradable, and Wireless Triboelectric Devices for Cancer Therapy Through Disrupting Microtubule and Actins Dynamics.  ADVANCED MATERIALS,      [PMID:37392034] [10.1002/adma.202303962]
3. Zhuang Yu, Wang Yuxiao, Li Ning, Meng Haitao, Li Zhiyu, Luo Jianguang, Qiu Zhixia.  (2023)  Hydrolytic Metabolism of Withangulatin A Mediated by Serum Albumin Instead of Common Esterases in Plasma.  EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS,  48  (4): (363-376).  [PMID:37344636] [10.1007/s13318-023-00834-8]
4. Jiawei Li, Chunmei Fan, Zhongyang Lv, Ziying Sun, Jie Han, Maochun Wang, Huiming Jiang, Kuoyang Sun, Guihua Tan, Hu Guo, Anlong Liu, Heng Sun, Xingquan Xu, Rui Wu, Wenjin Yan, Qing Jiang, Shiro Ikegawa, Xiao Chen, Dongquan Shi.  (2023)  Microtubule stabilization targeting regenerative chondrocyte cluster for cartilage regeneration.  Theranostics,      [PMID:37351173] [10.7150/thno.85077]
5. Rengui Xu, Honglian Guo, Xiuli Chen, Jiarong Xu, Yusheng Gong, Peng Cao, Chunyu Wei, Fei Xiao, Di Wu, Wei Chen, Lin Wang, Zheng Wang.  (2023)  Smart hydrothermally responsive microneedle for topical tumor treatment.  JOURNAL OF CONTROLLED RELEASE,      [PMID:37182803] [10.1016/j.jconrel.2023.05.008]
6. Qinhui Ren, Yufu Ma, Fuhua Wei, Lan Qin, Hongliang Chen, Zhao Liang, Siyuan Wang.  (2023)  Preparation of Zr-MOFs for the adsorption of doxycycline hydrochloride from wastewater.  Green Processing and Synthesis,  12  (1):   [PMID:] [10.1515/gps-2022-8127]
7. Tan Hu, Yang Xu, Gang Xu.  (2023)  Dipeptide-polysaccharides hydrogels through co-assembly.  FOOD CHEMISTRY,      [PMID:37141751] [10.1016/j.foodchem.2023.136272]
8. Fang Fang, Shaohua Zhang, Chaofan Chen, Xueying Wang, Chuannan Luo, Qin Wei.  (2023)  A fluorescent nanoprobe based on N/S co-doped carbon dots coupled with molecularly imprinted polymers for the detection of curcumin.  OPTICAL MATERIALS,      [PMID:] [10.1016/j.optmat.2023.113800]
9. Zhen Yu, Xundou Li, Jinhong Duan, Xian-Da Yang.  (2023)  Targeted Treatment of Colon Cancer with Aptamer-Guided Albumin Nanoparticles Loaded with Docetaxel.  International Journal of Nanomedicine,      [PMID:32982230] [10.2147/IJN.S267177]
10. Tong Le, Zhou ZeYang, Wang Gang, Wu Chao.  (2022)  A self-microemulsion enhances oral absorption of docetaxel by inhibiting P-glycoprotein and CYP metabolism.  Drug Delivery and Translational Research,  13  (4): (983-993).  [PMID:36515864] [10.1007/s13346-022-01255-x]
11. Li Huang, Huaqiang Fang, Teng Zhang, Binbin Hu, Shichen Liu, Fanzhen Lv, Zhaoxia Zeng, Huijie Liu, Weimin Zhou, Xiaolei Wang.  (2022)  Drug-loaded balloon with built-in NIR controlled tip-separable microneedles for long-effective arteriosclerosis treatment.  Bioactive Materials,      [PMID:36514389] [10.1016/j.bioactmat.2022.11.015]
12. Ruifeng Wu, Zhiqiang Zhang, Baohua Wang, Ge Chen, Yaozhong Zhang, Haowen Deng, Zilong Tang, Junjie Mao, Lei Wang.  (2022)  Combination Chemotherapy of Lung Cancer – Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid–Polymer Hybrid Nanoparticles.  Drug Design Development and Therapy,      [PMID:32606595] [10.2147/DDDT.S246574]
13. Dongsheng Fu, Jinhui You, Ruijie Guo, Jie Zhang, Qiang Li, Jing Wen, Huifang Wang, Hong Yan.  (2022)  Preparation of Nanostructured Graphene Oxide and Its Application in Drug Loading and Sustained Release.  ChemistrySelect,  (30): (e202200670).  [PMID:] [10.1002/slct.202200670]
14. Hongming Liu, Qin Zhou, Yongfu Lian.  (2022)  Polymethyl(1–Butyric acidyl)silane–Assisted Dispersion and Density Gradient Ultracentrifugation Separation of Single–Walled Carbon Nanotubes.  Nanomaterials,  12  (12): (2094).  [PMID:35745430] [10.3390/nano12122094]
15. Lingling Xu, Chuan Zhou, Fan Wang, Huiqin Liu, Guangyuan Dong, Siyi Zhang, Tao Liu.  (2022)  Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells.  RSC Advances,  12  (28): (18004-18011).  [PMID:35765336] [10.1039/D2RA02301F]
16. Wei Pei, Ling Cai, Xing Gong, Li Zhang, Jiarong Zhang, Ping Zhu, Huijun Jiang, Chao Wang, Shoulin Wang, Jin Chen.  (2022)  Drug-loaded oleic-acid grafted mesoporous silica nanoparticles conjugated with α-lactalbumin resembling BAMLET-like anticancer agent with improved biocompatibility and therapeutic efficacy.  Materials Today Bio,      [PMID:35607417] [10.1016/j.mtbio.2022.100272]
17. Yingying Zhang, Hongxia Duan, Heming Zhao, Lingling Qi, Yanhong Liu, Zheao Zhang, Chao Liu, Liqing Chen, Mingji Jin, Youyan Guan, Zhonggao Gao, Wei Huang.  (2022)  Development and Evaluation of a PSMA-Targeted Nanosystem Co-Packaging Docetaxel and Androgen Receptor siRNA for Castration-Resistant Prostate Cancer Treatment.  Pharmaceutics,  14  (5): (964).  [PMID:35631549] [10.3390/pharmaceutics14050964]
18. Jia Gao, Li Chen, Yongsheng Yan, Jian Lu, Wendong Xing, Jiangdong Dai, Minjia Meng, Yilin Wu.  (2021)  Dot-matrix-initiated molecularly imprinted nanocomposite membranes for selective recognition: a high-efficiency separation system with an anti-oil fouling layer.  Environmental Science-Nano,  (10): (2932-2949).  [PMID:] [10.1039/D1EN00296A]
19. Yingying Chai, Yuefei Wang, Bingqi Li, Wei Qi, Rongxin Su, Zhimin He.  (2021)  Microfluidic Synthesis of Lignin/Chitosan Nanoparticles for the pH-Responsive Delivery of Anticancer Drugs.  LANGMUIR,      [PMID:34078082] [10.1021/acs.langmuir.1c00778]
20. Ruiqi Xu, Mengnan Zeng, Yuanyuan Wu, Shengchao Wang, Beibei Zhang, Jingke Zhang, Yuxuan Kan, Benke Li, Bing Cao, Xiaoke Zheng, Weisheng Feng.  (2021)  Acetone Extract of Cornus officinalis Leaves Exerts Anti-Melanoma Effects via Inhibiting STAT3 Signaling.  OncoTargets and Therapy,      [PMID:34093025] [10.2147/OTT.S308371]
21. Wenjia Wang, Xiaoqin Zhang, Zhiqian Li, Dayi Pan, Hongyan Zhu, Zhongwei Gu, Jie Chen, Hu Zhang, Qiyong Gong, Kui Luo.  (2021)  Dendronized hyaluronic acid-docetaxel conjugate as a stimuli-responsive nano-agent for breast cancer therapy.  CARBOHYDRATE POLYMERS,      [PMID:34119134] [10.1016/j.carbpol.2021.118160]
22. Zhirong Zhu, Guiliang Tang, Jiajun Yan.  (2020)  MicroRNA‑122 regulates docetaxel resistance of prostate cancer cells by regulating PKM2.  Experimental and Therapeutic Medicine,  20  (6): (1-1).  [PMID:33178345] [10.3892/etm.2020.9377]
23. Hongyan Zhang, Shuang Dong, Sheng Zhang, Yufen Li, Ji Li, Yinghui Dai, Dongkai Wang.  (2020)  pH-responsive lipid polymer hybrid nanoparticles (LPHNs) based on poly (β-amino ester) as a promising candidate to resist breast cancers.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,      [PMID:] [10.1016/j.jddst.2020.102102]
24. Yuan He, Zhuyifan Ye, Xinyang Liu, Zhengjie Wei, Fen Qiu, Hai-Feng Li, Ying Zheng, Defang Ouyang.  (2020)  Can machine learning predict drug nanocrystals?.  JOURNAL OF CONTROLLED RELEASE,      [PMID:32234511] [10.1016/j.jconrel.2020.03.043]
25. Tian'e Chen, Liangxing Tu, Ge Wang, Na Qi, Wei Wu, Wei Zhang, Jianfang Feng.  (2020)  Multi-functional chitosan polymeric micelles as oral paclitaxel delivery systems for enhanced bioavailability and anti-tumor efficacy.  INTERNATIONAL JOURNAL OF PHARMACEUTICS,      [PMID:32018019] [10.1016/j.ijpharm.2020.119105]
26. Yao Yang, Zhengwei Huang, Jinyuan Li, Ziran Mo, Ying Huang, Cheng Ma, Wenhao Wang, Xin Pan, Chuanbin Wu.  (2019)  PLGA Porous Microspheres Dry Powders for Codelivery of Afatinib-Loaded Solid Lipid Nanoparticles and Paclitaxel: Novel Therapy for EGFR Tyrosine Kinase Inhibitors Resistant Nonsmall Cell Lung Cancer.  Advanced Healthcare Materials,  (23): (1900965).  [PMID:31664795] [10.1002/adhm.201900965]
27. Jiafeng Gao, Kai Fan, Yipeng Jin, Linna Zhao, Qian Wang, Yinian Tang, Huihao Xu, Zhongjie Liu, Shuaiyu Wang, Jiahao Lin, Degui Lin.  (2019)  PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden.  EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES,      [PMID:31518679] [10.1016/j.ejps.2019.105070]
28. Wei Fu, Zhiming Hong, Xujun You, Jing Din, Baishu Chen, Beibei Zhao, Gengyan Yuan, Qixin Li.  (2019)  Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer.  BIOMEDICINE & PHARMACOTHERAPY,      [PMID:31545228] [10.1016/j.biopha.2019.109374]
29. Tao Liu, Jingzhen Li, Xidong Wu, Siyi Zhang, Zhongming Lu, Guanxue Li, Junzheng Li, Shaohua Chen.  (2019)  Transferrin-targeting redox hyperbranched poly(amido amine)-functionalized graphene oxide for sensitized chemotherapy combined with gene therapy to nasopharyngeal carcinoma.  DRUG DELIVERY,      [PMID:31340676] [10.1080/10717544.2019.1642421]
30. Ting Zhao, Shiwei Qin, linna Peng, Pan Li, Tao Feng, Jingyuan Wan, Pei Yuan, Liangke Zhang.  (2019)  Novel hyaluronic acid-modified temperature-sensitive nanoparticles for synergistic chemo-photothermal therapy.  CARBOHYDRATE POLYMERS,      [PMID:30925992] [10.1016/j.carbpol.2019.03.043]
31. Ruoning Wang, Mengmeng Yang, Guoyuan Li, Xin Wang, Zhenhai Zhang, Hongzhi Qiao, Jun Chen, Zhipeng Chen, Xiaobin Cui, Junsong Li.  (2018)  Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity.  COLLOIDS AND SURFACES B-BIOINTERFACES,      [PMID:30469048] [10.1016/j.colsurfb.2018.11.029]
32. Lei Xu, Shuo Wu, Xiaoqiu Zhou.  (2018)  Bioinspired nanocarriers for an effective chemotherapy of hepatocellular carcinoma.  JOURNAL OF BIOMATERIALS APPLICATIONS,      [PMID:29699442] [10.1177/0885328218772721]
33. Ling-Yuan Guo, Shu-Zhen Yan, Qiang Li, Qiao Xu, Xi Lin, Shan-Shan Qi, Shu-Qin Yu, Shuang-Lin Chen.  (2017)  Poly(lactic-co-glycolic) acid nanoparticles improve oral bioavailability of hypocrellin A in rat.  RSC Advances,  (67): (42073-42082).  [PMID:] [10.1039/C7RA04748G]
34. Lin Yu, Xiaofeng Wu, Min Chen, Huarong Huang, Yan He, Huaqian Wang, Dongli Li, Zhiyun Du, Kun Zhang, Susan Goodin, Xi Zheng.  (2017)  The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer.  International Journal of Medical Sciences,      [PMID:28553168] [10.7150/ijms.18382]
35. Enhui Zhang, Ronge Xing, Song Liu, Kecheng Li, Yukun Qin, Huahua Yu, Pengcheng Li.  (2017)  Comparison in docetaxel-loaded nanoparticles based on three different carboxymethyl chitosans.  INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,      [PMID:28389400] [10.1016/j.ijbiomac.2017.03.195]
36. Zejun Xu, Yi Zhang, Qian Hu, Qiao Tang, Jiake Xu, Jianping Wu, Thomas Brett Kirk, Dong Ma, Wei Xue.  (2016)  Biocompatible hyperbranched polyglycerol modified β-cyclodextrin derivatives for docetaxel delivery.  Materials Science & Engineering C-Materials for Biological Applications,      [PMID:27987795] [10.1016/j.msec.2016.11.005]
37. Xiaoyan Zhou, Qianqian Zheng, Changyong Wang, Jiake Xu, Jian-Ping Wu, Thomas Brett Kirk, Dong Ma, Wei Xue.  (2016)  Star-Shaped Amphiphilic Hyperbranched Polyglycerol Conjugated with Dendritic Poly(l-lysine) for the Codelivery of Docetaxel and MMP-9 siRNA in Cancer Therapy.  ACS Applied Materials & Interfaces,      [PMID:27153187] [10.1021/acsami.6b01611]
38. De-Hong Yu, Ya-Rong Liu, Xin Luan, Hai-Jun Liu, Yun-Ge Gao, Hao Wu, Chao Fang, Hong-Zhuan Chen.  (2015)  IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.  BIOCONJUGATE CHEMISTRY,      [PMID:26076081] [10.1021/acs.bioconjchem.5b00283]
39. Chang-Wei Li, Hua-Jin Dong, Cheng-Bin Cui.  (2015)  The Synthesis and Antitumor Activity of Twelve Galloyl Glucosides.  MOLECULES,  20  (2): (2034-2060).  [PMID:25633333] [10.3390/molecules20022034]
40. Chao Yang, Lina Han, Fei Ma, Lin Zhou, Jiahong Zhou, Shaohua Wei, Guiqin Huang, Jian Shen, Fuyou Li.  (2013)  Synthesis of Calcium Phosphate Nanoparticle-Based Docetaxel Delivery System and its In Vitro Anticancer Activity.  International Journal of Applied Ceramic Technology,  12  (2): (300-305).  [PMID:] [10.1111/ijac.12159]
41. Jiang Xiaoqian, Qu Aihua, Xu Xinxin, Kuang Hua, Liu Liqiang, Xu Chuanlai.  (2024)  A gold-based multiplex immunochromatographic sensor for detecting paclitaxel, methotrexate, and 5-fluorouracil in clinical samples.  Nano Research,      [PMID:] [10.1007/s12274-024-6649-7]
42. Yaowei Zhu, Ruijie Tang, Jun Zhao, Changlong Jiang, Lingfei Li, Bianhua Liu.  (2025)  Design and application of metal-organic framework based chemo-fluorescent sensor for selective sensing of the full spectrum of tetracyclines in complex samples.  CHEMICAL ENGINEERING JOURNAL,      [PMID:] [10.1016/j.cej.2025.160281]
43. Yuanxin Pian, Yan Hao, Yuxin Guo, Shiqi Wu, Saijiao Tang, Jiaqi Li, Xinya Lu, Xiaoya Sun, Zhaowen Tan, Tianyu Zhu, Yuxiang Tang, Defeng Xu, Hang Hu.  (2025)  Exploration of using α-crocin for drug encapsulation and delivery.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,      [PMID:] [10.1016/j.jddst.2025.106716]
44. Xiaojing Zhang, Yansong Chen, Jingwei Tang, Chen Chen, Yanfeng Sun, Hao Zhang, Mengxiang Qiao, Gongsheng Jin, Xianfu Liu.  (2024)  GSH-activable heterotrimeric nano-prodrug for precise synergistic therapy of TNBC.  BIOMEDICINE & PHARMACOTHERAPY,      [PMID:38460372] [10.1016/j.biopha.2024.116375]
45. Ying Li, Xiaoying Liu, Jie Wang, Si Li.  (2024)  High-generation tetracyclines shifted microbial community composition and induced the emergence of antibiotic resistant bacteria in soil.  JOURNAL OF HAZARDOUS MATERIALS,      [PMID:39259998] [10.1016/j.jhazmat.2024.135757]
46. Han Zhang, Fang Fang, Jiangle Yi, Yuanling Sun, Xueying Wang.  (2025)  Molecularly imprinted polymer coupled with zinc-doped carbon quantum dots as a fluorescent probe for the determination of doxorubicin hydrochloride.  NEW JOURNAL OF CHEMISTRY,  49  (8): (3200-3206).  [PMID:] [10.1039/D4NJ05142D]
47. Longxin Lin, Yaling Zheng, Caixia Huang, Lanlan Cai, Hua Zhang, Wen Xu, Xiaoying Wang, Wei Xu.  (2024)  Oral and tumor-targeting mixed micelles based on pegylated biotin and chitosan-based conjugate for breast cancer treatment.  EUROPEAN POLYMER JOURNAL,      [PMID:] [10.1016/j.eurpolymj.2024.113592]
48. Jia Yu, Qian Liu, Yuejiao Zhang, Lingfeng Xu, Xiaohua Chen, Feng He, Mian Zhang, Hongxu Yang, Shibing Yu, Xin Liu, Yaoping Wu, Meiqing Wang.  (2024)  Stress causes lipid droplet accumulation in chondrocytes by impairing microtubules.  OSTEOARTHRITIS AND CARTILAGE,      [PMID:39730095] [10.1016/j.joca.2024.08.015]
49. Xueyan Hou, Jingya Zhao, Jingjing Xu, Yuxin Wang, Hongyan Xu, Qinghe Gao, Yalin Guan, Yiqiu Xiong, Sisi He, Yongli Shi.  (2024)  Tumor Microenvironment-Responsive Ternary Nanosystem for Enhanced Antitumor and Antimetastasis Efficacy Against Breast Cancer.  ACS Applied Nano Materials,      [PMID:] [10.1021/acsanm.4c06164]
50. Hui-Qin Liu, Xi-Dong Wu, Xue-Wen Fang, Yun-Song An, Meng Xia, Xiao-Hua Luo, Jun-Zheng Li, Guan-Hai Wang, Tao Liu.  (2024)  Tumor-Targeted Magnetic Micelles for Magnetic Resonance Imaging, Drug Delivery, and Overcoming Multidrug Resistance.  ACS Omega,      [PMID:39713686] [10.1021/acsomega.4c07132]
51. Liyun Ma, Zhi Li, Yiyi Shi, Yuchen Xie, Ming Jiang, Xu Yu, Li Xu.  (2024)  Two Birds With One Stone: A Novel Nanocomposite Combining Silicon Nanoparticles and Carbon-Doped Titania as the Fluorescence Probe and Visible Light Photocatalyst for Simultaneous Detection and Removal of Oxytetracycline.  Advanced Science,      [PMID:39651852] [10.1002/advs.202410306]
52. Jingmei Zhou, Min Lin, Yan Mo, Ruiyue Dang, Jin Zhou, Chengmin Li, Xin Deng, Alaa Aldeen Alsaeedi, Yingqi Zhao, Juan Huang, Lijuan Ma, Xueping Feng, Yong Liu, Yunyun Wang.  (2025)  Formation and evaluation of docetaxel and triptolide polymer micelles for anti-cancer activity.  Nanomedicine,      [PMID:40736067] [10.1080/17435889.2025.2535281]
53. Ye Zhou, Simeng Wang, Jiahua Guo, Chenghao Li, Mengjun Sui, Zekun Zeng, Hui Dang, Qingqing Gu, Jian Zhu, Yangyang Cheng, Peng Hou.  (2024)  Harnessing transcription factor-driven ROS for synergistic multimodal lung cancer treatment.  JOURNAL OF CONTROLLED RELEASE,      [PMID:39182692] [10.1016/j.jconrel.2024.08.035]
54. Guobo Chen, Jing Ping, Jun Du, Linghao Zhao, Yuhao Li, Hui Liu.  (2024)  Glutathione and acid dual-responsive bismuth-based nanosensitizer for chemo-mediated cancer sonodynamic therapy.  Biomedical Materials,  19  (4): (045035).  [PMID:38857606] [10.1088/1748-605X/ad565c]
55. Yuan Lin, Chuangnan Li, Kaijie Cen, Jucai Xu, Jing Chen.  (2024)  Fabrication, characterization, and in vitro biological evaluation of glycyrrhetinic acid ligand-functionalized proliposomes encapsulated docetaxel for treatment of hepatocellular carcinoma.  COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS,      [PMID:] [10.1016/j.colsurfa.2024.135802]
56. Ru Li, Yimei Ma, Anqi He, Yamin Pu, Xuanting Wan, Hongbao Sun, Ningyu Wang, Min Luo, Guan Wang, Yong Xia.  (2025)  Fasting enhances the efficacy of Sorafenib in breast cancer via mitophagy mediated ROS-driven p53 pathway.  FREE RADICAL BIOLOGY AND MEDICINE,      [PMID:39864757] [10.1016/j.freeradbiomed.2025.01.047]
57. You Xujun, Li Honghan, Li Qixin, Zhang Qing, Cao Yiguo, Fu Wei, Wang Bin.  (2025)  Astragaloside IV-PESV facilitates pyroptosis by enhancing palmitoylation of GSDMD protein mediated by ZDHHC1.  NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY,      [PMID:40237800] [10.1007/s00210-025-04122-x]
58. Kong Linghui, Hu Song, Zhao Ying, Huang Yan, Xiang Xiaobing, Yu Yang, Mao Xiaochun, Xie Kangjie, Zhu Xiaoyan, Xu Pingbo.  (2025)  Neutrophil extracellular traps induced by neoadjuvant chemotherapy of breast cancer promotes vascular endothelial damage.  BREAST CANCER RESEARCH,  27  (1): (1-19).  [PMID:40270028] [10.1186/s13058-025-02011-y]
59. Yang Wang, Dianpeng Li, Min He, Gang Wang, Shulin Zhao.  (2025)  Remodeling the Tumor Microenvironment via Metal-Phenolic Network-Coated Poly(lactic acid-co-glycolic acid) Nanoparticles for Inducing Multimodal Combination Therapy in Non-Small Cell Lung Cancer.  ACS Applied Bio Materials,      [PMID:40556407] [10.1021/acsabm.5c00634]
60. Chen Biqing, Gao Jiayin, Sun Haizhu, Zhao Yinghan, Liu Yan, Lv Xinpeng, Qiu Xiaohong, Li Yang.  (2025)  Application of surface-enhanced Raman scattering combined with artificial intelligence for multiplex detection of chemotherapeutic agents used in solid tumors.  ANALYTICAL AND BIOANALYTICAL CHEMISTRY,      [PMID:41324706] [10.1007/s00216-025-06241-z]
61. Sai-Nan Qin, Yi-Xue Zhang, Yi-Jie Cao, Ting Wan, Yi-Yang Zhou, Shan-Shan Su, Yu-Qiong Guo, Jian-Jun Sun, Kalle Salminen.  (2026)  A self-assembled electrochemical aptasensor for one-step rapid detection of cisplatin in blood via aptamer conformational change.  MICROCHEMICAL JOURNAL,      [PMID:] [10.1016/j.microc.2026.116962]
62. Yangyang Song, Xue Tan, Kai Yu, Yue Wang, Jixue Wang.  (2026)  Tumor-responsive PEGylated mesoporous nanoparticles achieve enhanced chemotherapy and reduced toxicity in prostate cancer.  International Journal of Pharmaceutics-X,      [PMID:41675220] [10.1016/j.ijpx.2026.100492]
63. Xinying Wang, Xianlu Zhang, Zixuan Jiao, Shipeng Ning, Hanping Wang, Hui Liu, Lifen He, Haonan Li, Mingzhong Li, Kaiyuan Wang, Zhonggui He, You Pan.  (2026)  An Exosome-Inspired Docetaxel Prodrug Nanoplatform for Potent STING Activation and Synergistic Chemoimmunotherapy.  Asian Journal of Pharmaceutical Sciences,      [PMID:] [10.1016/j.ajps.2026.101139]
64. Ying He, Nengbin Wan, Hongwu Deng, Yi Zhang, Qiang Liu, Li Li, Hao Liu, Xiao He, Qing Zhu.  (2026)  cRGD-modified, pH-sensitive liposomes for co-delivery of docetaxel and ABCG2 siRNA enhance therapeutic efficacy in triple-negative breast cancer.  COLLOIDS AND SURFACES B-BIOINTERFACES,      [PMID:] [10.1016/j.colsurfb.2026.115616]
65. Tong Zhao, Luying Xu, Wenjie Huang, Cong Wang, Huanhuan Wang, Mengyue Du, Chang Yao, Yanlei Xu.  (2026)  Chrysophanol Attenuates Breast Cancer Angiogenesis Through Blocking VEGFA/VEGFR2/ERK Activation via Inhibiting ACE2 Ubiquitination.  EUROPEAN JOURNAL OF PHARMACOLOGY,      [PMID:] [10.1016/j.ejphar.2026.178810]
66. Wang Weilin, Hu Qiaoying, Wu Chunyan, Ding Jiayue, Zhu Chuanxiu, Wen Jiayao, Li Yingchao, Yang Menghan, Wang Yujie, Sun Deqing, Zhai Guangxi, Zhang Yanan.  (2026)  A ferroptosis-based intelligent nanoplatform with chemo-sonodynamic therapy carrying oxygen for improving tumor suppression and antitumor immunity.  JOURNAL OF NANOBIOTECHNOLOGY,      [PMID:] [10.1186/s12951-026-04409-y]
Solution Calculators
Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.